期刊文献+

他克莫司通过稳定细胞骨架和nephrin抑制血管紧张素Ⅱ损伤肾小球足细胞 被引量:3

Tacrolimus inhibits podocyte injury and stabilizes the expression of cytoskeleton and nephrin
下载PDF
导出
摘要 目的探讨他克莫司(Tac)在足细胞损伤中的作用机制。方法以血管紧张素Ⅱ(AngⅡ),或AngⅡ联合Tac干预体外培养足细胞,干预后0、12和24 h收集细胞;行荧光染色观察细胞骨架分布,以WB检测足细胞分子nephrin和podocin蛋白表达。结果对照组骨架分子F-actin呈强有力丝状排列,AngⅡ引起F-actin的断裂和不连续分布,Tac明显抑制AngⅡ对F-actin的损坏,维持细胞骨架良好的丝状结构。AngⅡ刺激后24 h,nephrin表达明显低于对照组,Tac抑制AngⅡ对nephrin的下调(1.00±0.19 vs.0.76±0.32,P<0.05),稳定nephrin正常表达;AngⅡ和Tac干预对podocin表达无明显影响。结论 Tac抑制AngⅡ损伤足细胞,稳定细胞骨架的规律排列和nephrin的正常表达。 Objective To investigate the function and molecular mechanism of tacrolimus in podocyte injury and restoration. Methods Cultured podocytes were stimulated by Angiotensin Ⅱ (Ang Ⅱ ) or Ang Ⅱ plus tacrolimus. Cells were collected at different time points ( 0 h, 12 h and 24 h ). The distribution of F-actin was observed after immunofluorescenee staining, and the protein expression of nephrin and podocin were detected by Western Blot (WB). Results In normal control podocytes, F-actin was arranged in cytoplasm powerfully. Ang Ⅱ induced the disruption and discontinuity of F-actin. Tacrolimus inhibited the effect of Ang Ⅱ , stabilized the regular arrangement the F-actin. Compared to normal cells, the protein expression of nephrin in Ang Ⅱ group significantly decreased at 24 h after stimulation (0.76 ± 0.32 in Ang Ⅱ group vs. 1.18 ± 0.40 in normal group, P 〈 0.05). And tacrolimus stabilized the expression of nephrin protein (1.00 ±0.19 in treatment group vs. 0.76 ± 0.32 in Ang Ⅱ group, P 〈 0.05). Ang Ⅱ and tacrolimus did not affect the expression of podocin protein. Conclusion Tacrolimus inhibits podocyte injury induced by Ang Ⅱ , stabilizes the regular arrangement of cytoskeleton and protein expression of nephrin.
出处 《实用医学杂志》 CAS 北大核心 2017年第22期3694-3697,共4页 The Journal of Practical Medicine
基金 广州市医药卫生科技项目(编号:20161A011073 20161A011074)
关键词 肾小球足细胞 他克莫司 细胞骨架 NEPHRIN podocyte tacrolimus cytoskeleton nephrin
  • 相关文献

参考文献1

二级参考文献15

  • 1马瑞霞,刘雪梅,刘丽秋,李海娜.雷公藤甲素对2型糖尿病大鼠肾组织足细胞Nephrin、Podocin蛋白表达的影响及机制[J].中华糖尿病杂志,2010,2(4). 被引量:11
  • 2梁超,袁亮,吴永贵,董婧,任克军,张炜,方芳,郝丽,张伯科.FK506对糖尿病大鼠早期肾脏肥大的抑制作用及机制[J].中华肾脏病杂志,2007,23(4):230-234. 被引量:12
  • 3Teng B, Duong M, Tossidou I, et al. Role of protein kinase C in podocytes and development of glomerular damage in diabetic ne- phropathy[J]. Front Endocrinol (Lausanne), 2014,5 179.
  • 4Ma R, Liu L, Liu X, et al. Triptolide markedly attenuates albu-minuria and podocyte injury in an animal model of diabetic ne- phropathy[J]. Exp Ther Med, 2013,6 (3) : 649-656.
  • 5Liu HF, Guo LQ, Huang YY, et al. Thiazolidinedione attenuate proteinuria and glomerulosclerosis in adriamycin-induced nephropathy rats via slit diaphragm protection[J]. Nephrology, 2010,15 (1) : 75 83.
  • 6Liu Y, Ji Z, FK506 alleviates proteinuria in rats with adriamycin- induced nephropathy by down-regulating TRPC6 and CaN expres- sion[J]. J Nephrol,2012,25(6) :918-925.
  • 7Lin CL, Wang FS, Hsu YC, et al. Modulation of Notch-1 signa- ling alleviates VEGF-mediated diabetic nephropathy[J]. Diabetes, 2010,59(8) : 1915-1925.
  • 8Toyoda M, Najafian B, Kim Y, et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type1 diabetic nephropathy[J]. Diabetes,2007,56(8) :2155-2160.
  • 9Eid AA, Ford BM, Basant B, et al. Mammalian target of rapam- ycin regulates Nox4-mediated podocyte depletion in diabetic renal injury[J]. Diabetes, 2013,62 (8) : 2935-2947.
  • 10Ma R, Xu Y, Jiang W, et al. Combination of Tripterygium wilfordii Hook F and angiotensin receptor blocker synergistically reduces excretion of urinary podocytes in patients with type 2 diabetic kidney disease[J]. Biotechnol Biotechnol Equip,2015,29(1) 139-146.

共引文献1

同被引文献25

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部